RSS Feed
Biotech Stock Mailbag: FDA Playbook
Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.
06:01AM 11/20/09
U.S. Sees Low Demand for BioCryst Flu Drug
Peaking flu season could mean no need for further peramivir orders.
11:12AM 11/18/09
Another Genzyme Drug Goes Kaboom: BioBuzz
Company halts development of kidney disease drug following poor test results.
08:05AM 11/18/09
Vivus Seeks Faster ED Drug: Biobuzz
Company says ED drug met all goals in phase III study.
06:42AM 11/18/09
Genzyme's Termeer: Worst Biotech CEO of '09
Genzyme CEO Henri Termeer is Adam Feuerstein's Worst Biotech CEO of the Year for 2009.
12:31PM 11/17/09
InterMune Hep C Drug Hit With Liver Tox Worry: BioBuzz
Safety monitors force change to mid-stage study of ITMN-191
09:11AM 11/17/09
Poniard's CEO Pulls a Belichik: BioBuzz
Risky late-game call puts Poniard in a deep financial hole.
11:59AM 11/16/09
A Closer Look at Cardium's Wound-Healing Drug: BioBuzz
Is it the drug or the gel that worked best in a phase II study?
10:51AM 11/16/09
Cell Therapeutics Lavishes Free Stock on Execs: BioBuzz
'Retention' bonus awarded to CEO Jim Bianco, his management team and directors.
09:23AM 11/16/09
Poniard Cancer Drug Fails Pivotal Study: BioBuzz
Lung cancer drug picoplatin doesn't prolong survival in phase III study.
07:22AM 11/16/09
Connect with TheStreet